Hyuk J. Moon
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer Therapy.
Journal: Pharmaceutics
Published: August 29, 2025
Kinase suppressor of Ras 1 (KSR1) promotes liver carcinogenesis via activation of the RAS/RAF/MEK/ERK signaling pathway.
Journal: JHEP reports : innovation in hepatology
Published: January 24, 2025
Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications.
Journal: International journal of molecular sciences
Published: August 23, 2023
Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma.
Journal: Pharmaceutics
Published: July 25, 2023
Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma.
Journal: International journal of molecular sciences
Published: November 02, 2021
Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways.
Journal: BMC cancer
Published: October 26, 2021
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer.
Journal: Translational oncology
Published: February 08, 2021
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation.
Journal: Hepatology (Baltimore, Md.)
Published: September 05, 2020
Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma.
Journal: Journal of liver cancer
Published: June 24, 2020
Last Updated: 09/26/2026